MORGAN DAHMS: Open Payments
NPI 1225602931 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 83 payments from 14 companies in 2025. Trend: 2023 $1,171 · 2024 $1,299 · 2025 $1,552
Food & beverage: $1,552
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $411 |
| GENZYME CORPORATION | 13 | $259 |
| GlaxoSmithKline, LLC. | 22 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $156 |
| Globus Medical, Inc. | 3 | $145 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Genentech USA, Inc. | 2 | $46 |
| CSL Behring | 2 | $44 |
| Amgen Inc. | 1 | $28 |
Products named: DUPIXENT, TEZSPIRE, Senza, BREZTRI, NUCALA, CUVITRU, TRELEGY ELLIPTA, Xolair.
Industry payments across CO — which companies pay providers there.
